These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6192967)

  • 21. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 25. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilator therapy for primary pulmonary hypertension.
    Palevsky HI; Fishman AP
    Annu Rev Med; 1985; 36():563-78. PubMed ID: 2859832
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vasodilator agents in the treatment of cardiac insufficiency].
    Bertel O
    Ther Umsch; 1984 Feb; 41(2):117-24. PubMed ID: 6424258
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
    Tamura M; Kurumatani H; Matsushita T
    Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Individual approach to vasodilator treatment of pulmonary hypertension in chronic bronchitis].
    Volkova LI; Shteĭngart IuN
    Klin Med (Mosk); 1994; 72(6):66-7. PubMed ID: 7898022
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of vasodilators on the resistance vessels of the forearm in patients with essential hypertension].
    Robinson BF
    Rev Esp Cardiol; 1983; 36(6):469-71. PubMed ID: 6675080
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension (author's transl)].
    Hoshino T; Handa S; Akizuki S; Hori S; Norisue H; Hori A; Fukui T
    Kokyu To Junkan; 1981 Mar; 29(3):291-5. PubMed ID: 7255981
    [No Abstract]   [Full Text] [Related]  

  • 37. Hope in primary pulmonary hypertension.
    Reeves JT
    N Engl J Med; 1980 Jan; 302(2):112-3. PubMed ID: 7350416
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
    Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulmonary circulation in primary pulmonary hypertension during hyperoxia and following drugs].
    Begenat H; Mürtz R
    Verh Dtsch Ges Inn Med; 1971; 77():1096-9. PubMed ID: 5005543
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of heart failure with vasodilators].
    Bolte HD
    Internist (Berl); 1980 Dec; 21(12):753-9. PubMed ID: 6451599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.